Jennifer Dennison
Jennifer Dennison
University of Texas MD Anderson Cancer Center
Verified email at
Cited by
Cited by
Comprehensive molecular portraits of invasive lobular breast cancer
G Ciriello, ML Gatza, AH Beck, MD Wilkerson, SK Rhie, A Pastore, ...
Cell 163 (2), 506-519, 2015
Antitumor activity of the glutaminase inhibitor CB-839 in triple-negative breast cancer
MI Gross, SD Demo, JB Dennison, L Chen, T Chernov-Rogan, B Goyal, ...
Molecular cancer therapeutics 13 (4), 890-901, 2014
Dual inhibition of tumor energy pathway by 2-deoxyglucose and metformin is effective against a broad spectrum of preclinical cancer models
JH Cheong, ES Park, J Liang, JB Dennison, D Tsavachidou, ...
Molecular cancer therapeutics 10 (12), 2350-2362, 2011
Selective metabolism of vincristine in vitro by CYP3A5
JB Dennison, P Kulanthaivel, RJ Barbuch, JL Renbarger, WJ Ehlhardt, ...
Drug metabolism and disposition 34 (8), 1317-1327, 2006
Effect of CYP3A5 expression on vincristine metabolism with human liver microsomes
JB Dennison, DR Jones, JL Renbarger, SD Hall
Journal of Pharmacology and Experimental Therapeutics 321 (2), 553-563, 2007
Quinoline 3-sulfonamides inhibit lactate dehydrogenase A and reverse aerobic glycolysis in cancer cells
J Billiard, JB Dennison, J Briand, RS Annan, D Chai, M Colón, ...
Cancer & metabolism 1 (1), 19, 2013
Lactate dehydrogenase B: a metabolic marker of response to neoadjuvant chemotherapy in breast cancer
JB Dennison, JR Molina, S Mitra, AM González-Angulo, JM Balko, ...
Clinical Cancer Research 19 (13), 3703-3713, 2013
Long noncoding RNA ceruloplasmin promotes cancer growth by altering glycolysis
R Rupaimoole, J Lee, M Haemmerle, H Ling, RA Previs, S Pradeep, ...
Cell reports 13 (11), 2395-2402, 2015
MCAM mediates chemoresistance in small-cell lung cancer via the PI3K/AKT/SOX2 signaling pathway
SC Tripathi, JF Fahrmann, M Celiktas, M Aguilar, KD Marini, MK Jolly, ...
Cancer research 77 (16), 4414-4425, 2017
A gel‐free MS‐based quantitative proteomic approach accurately measures cytochrome P450 protein concentrations in human liver microsomes
MZ Wang, JQ Wu, JB Dennison, AS Bridges, SD Hall, S Kornbluth, ...
Proteomics 8 (20), 4186-4196, 2008
Functional annotation of rare gene aberration drivers of pancreatic cancer
YH Tsang, T Dogruluk, PM Tedeschi, J Wardwell-Ozgo, H Lu, M Espitia, ...
Nature communications 7 (1), 1-11, 2016
Apparent high CYP3A5 expression is required for significant metabolism of vincristine by human cryopreserved hepatocytes
JB Dennison, MA Mohutsky, RJ Barbuch, SA Wrighton, SD Hall
Journal of Pharmacology and Experimental Therapeutics 327 (1), 248-257, 2008
Role of CPS1 in cell growth, metabolism, and prognosis in LKB1-inactivated lung adenocarcinoma
M Çeliktaş, I Tanaka, S Chandra Tripathi, JF Fahrmann, ...
JNCI: Journal of the National Cancer Institute 109 (3), 2017
PAK1 Is a Novel Therapeutic Target in Tyrosine Kinase Inhibitor–Resistant Lung Adenocarcinoma Activated by the PI3K/AKT Signaling Regardless of EGFR Mutation
DW Wu, TC Wu, CY Chen, H Lee
Clinical Cancer Research 22 (21), 5370-5382, 2016
A plasma-derived protein-metabolite multiplexed panel for early-stage pancreatic cancer
JF Fahrmann, LE Bantis, M Capello, G Scelo, JB Dennison, N Patel, ...
JNCI: Journal of the National Cancer Institute 111 (4), 372-379, 2019
Abortive autophagy induces endoplasmic reticulum stress and cell death in cancer cells
S Claerhout, B Dutta, W Bossuyt, F Zhang, C Nguyen-Charles, ...
PLoS One 7 (6), e39400, 2012
Quantification of vincristine and its major metabolite in human plasma by high-performance liquid chromatography/tandem mass spectrometry
JB Dennison, JL Renbarger, DO Walterhouse, DR Jones, SD Hall
Therapeutic drug monitoring 30 (3), 357-364, 2008
Preclinical activity of 8‐chloroadenosine with mantle cell lymphoma: roles of energy depletion and inhibition of DNA and RNA synthesis
JB Dennison, K Balakrishnan, V Gandhi
British journal of haematology 147 (3), 297-307, 2009
The relative contributions of CYP3A4 and CYP3A5 to the metabolism of vinorelbine
AR Topletz, JB Dennison, RJ Barbuch, CE Hadden, SD Hall, ...
Drug Metabolism and Disposition 41 (9), 1651-1661, 2013
Rab25 acts as an oncogene in luminal B breast cancer and is causally associated with Snail driven EMT
S Mitra, L Federico, W Zhao, J Dennison, TR Sarkar, F Zhang, V Takiar, ...
Oncotarget 7 (26), 40252, 2016
The system can't perform the operation now. Try again later.
Articles 1–20